Atlas Trials

Protgen Ltd

13 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch Protgen Ltd

RecordFirmDate
Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials (NCT06489015)Protgen Ltd2024-08-27
Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites (NCT06553456)Protgen Ltd2024-08-19
Phase II/III of Recombinant Human Serum Albumin (NCT05858853)Protgen Ltd2023-05-24
Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects (NCT05249374)Protgen Ltd2021-10-14
Recombinant Human Serum Albumin in Healthy Subjects (NCT05179265)Protgen Ltd2021-03-29
Clinical Trial of Quantitative Detection Kit for Hsp90α in Breast Cancer (NCT02324101)Protgen Ltd2013-04-01
Clinical Trial of Quantitative Detection Kit for Hsp90α in Hepatic Cancer (NCT02324127)Protgen Ltd2012-10-01
Clinical Trial of Quantitative Detection Kit for Hsp90α in Colorectal Cancer (NCT02324114)Protgen Ltd2012-09-01
Paclitaxel-Carboplatin Alone or With M2ES for Non-Small-Cell Lung Cancer (NCT01527864)Protgen Ltd2011-05-01
Study of M2ES in Patients With Advanced Pancreatic Cancer After Gemcitabine Treatment Failure (NCT01219192)Protgen Ltd2010-08-01
Study With M2ES and Gemcitabine for Patients With Advanced Pancreatic Cancer (NCT01218880)Protgen Ltd2010-06-01
Dose Escalation and PK Study of M2ES in Subjects With Advanced Solid Tumors (NCT01226030)Protgen Ltd2009-09-01
Single-dose Escalation Trial of M2ES in Healthy Volunteer (NCT01223924)Protgen Ltd2009-05-01

Track Protgen Ltd automatically

Every clearance here is in the API, with alerts when new ones post.